Restless legs drugs can backfire, so sleep doctors now check iron first

Key takeaways

• In a 2005 survey of more than 15,000 adults, 2.7% had restless legs symptoms at least twice a week with real distress, yet only about 6% of those who told a doctor got a diagnosis⁷.
• The American Academy of Sleep Medicine now suggests against routine use of pramipexole, ropinirole and related dopamine drugs, because over time they can make restless legs worse¹³.
• The same 2024 guideline asks clinicians to test ferritin and transferrin saturation in everyone with significant symptoms and to consider iron when ferritin is 75 ng/mL or lower or saturation is under 20%¹.
• Iron carries real risks: the adult upper limit from supplements is 45 mg a day unless a clinician prescribes more, and in September 2026 the FDA added a boxed warning about low phosphate to the IV iron the guideline rates highest⁹¹⁰.
• Among home approaches, exercise has the best support, from one small trial, while research on magnesium is too thin to say whether it helps¹³¹⁴.

In 2012, the American Academy of Sleep Medicine (AASM) gave strong recommendations to two drugs for restless legs syndrome: pramipexole (Mirapex) and ropinirole (Requip)².

Twelve years later, the academy changed course. Its new guideline, posted online in September 2024, suggests against the standard use of both drugs and their relatives¹³.

The reason has a name: augmentation. Over months or years, these medicines can make the condition itself worse. Symptoms start earlier in the day and may spread beyond the legs⁵.

John Winkelman of Massachusetts General Hospital, who chaired the guideline panel, told the medical news site HCPLive that augmentation affects about 7% to 10% of people on these drugs each year³.

The guideline also pushed something simpler to the front of the line: iron. That suits readers who like to start with what the body needs. But iron acts as a real medicine here, with real risks.

Restless legs is a brain disorder that doctors often miss

Restless legs syndrome, or RLS, is also called Willis-Ekbom disease. The National Institute of Neurological Disorders and Stroke (NINDS) counts it as a sleep disorder, because resting and trying to sleep set it off, and as a movement disorder, because people must move to get relief⁴.

People describe the feeling as aching, throbbing, pulling, itching, crawling or creeping inside the legs⁴. It usually affects both legs and sometimes the arms⁴. It tends to build in the evening and at night, then often fades in the early morning⁴.

Most people with RLS also have periodic limb movements of sleep: small leg jerks that repeat every 15 to 40 seconds⁴. RLS is more common in women and most often starts in middle age⁴.

How common it is depends on how you count

In the REST study, published in 2005, researchers questioned more than 15,000 adults⁷. About 7.2% had at least some symptoms in the past year, but only 2.7% had them twice a week or more with moderate or severe distress⁷.

That group mostly went undiagnosed. Of 416 people with frequent, distressing symptoms, 337 had discussed them with a primary care doctor. Just 21 had been told they had RLS, roughly 1 in 16 by our math⁷.

A 2017 NINDS booklet puts the figure at up to 7% to 10% of Americans⁵. That’s close to REST’s count of anyone with any symptoms, not just frequent, distressing ones⁷.

Low iron in the brain is a big part of the story

RLS often runs in families, and certain gene variants raise the risk⁴. But the strongest clue points to iron. NINDS says low iron in the brain may be responsible⁴. The problem also seems to involve the basal ganglia, a brain region that uses dopamine, a chemical messenger, to control movement⁴.

A ferritin of 15 or 20 might pass as normal on a routine report, but Winkelman calls that far too low for someone with RLS³. The guideline’s cutoffs sit far above that range¹.

Ferritin shows how much iron your body has stored¹¹. Transferrin is the protein that carries iron through your blood¹¹, and transferrin saturation shows how much of it is loaded with iron.

A 2019 Cochrane review pooled 10 trials with 428 adults, most of them using iron given through a vein (IV)⁸. Compared with a placebo, iron lowered symptom scores by about 3.8 points on a 40-point scale⁸.

The reviewers called that benefit low to moderate and rated their certainty as moderate⁸. Iron helped even when blood iron was normal at the start, and side effects were no more common than with placebo⁸.

One caution: drug makers paid for the four largest trials, and some finished studies were never published⁸.

Why the old first-choice drugs fell out of favor

Pramipexole, ropinirole, the rotigotine skin patch and levodopa all act on the brain’s dopamine system. The guideline panel judged that they work well in the short run³.

The trouble shows up later. NINDS describes augmentation as a gradual worsening caused by the medicine itself⁵. Symptoms may start earlier and earlier until they are present around the clock, and they may spread to the arms or trunk⁵. Stopping the drug can reverse it⁵.

A yearly risk of 7% to 10% sounds small, but RLS usually needs years of treatment. By Winkelman’s estimate, that adds up to 20% to 30% of patients within three years and 35% to 50% within five³. Raising the dose when symptoms creep back, he says, only speeds the process³.

So the AASM now suggests against “standard use” of these drugs¹. That is a conditional recommendation, not a ban. The panel says someone who values quick relief more than long-term risk may still choose one¹.

If you take one now, don’t stop or change the dose on your own. Ask your prescriber whether your symptoms have shifted.

Not every government page has caught up. The MedlinePlus encyclopedia entry, reviewed in July 2025, still lists pramipexole and ropinirole first among RLS medicines⁶.

What the 2024 guideline recommends now

The guideline rates evidence with GRADE, a standard system, and gives two levels of advice¹. Strong means the panel is confident it fits most patients. Conditional means the best choice depends more on the person.

Selected treatments for adults	Guideline’s call1	What to know
Gabapentin, gabapentin enacarbil, pregabalin	Strong, for	Possible dizziness, unsteady walking, weight gain; low starting doses help3
IV ferric carboxymaltose, if iron tests qualify	Strong, for	Not FDA-approved for RLS; new boxed warning on low phosphate10
Oral ferrous sulfate, if iron tests qualify	Conditional, for	Inexpensive; nausea and constipation are common9
Leg nerve stimulation device	Conditional, for	Prescription; tested in people medicines didn’t help12
Extended-release oxycodone and other opioids	Conditional, for	NINDS reserves them for severe cases that don’t respond to other treatment4
Levodopa, pramipexole, ropinirole, rotigotine	Conditional, against standard use	Augmentation35
Clonazepam, valerian, carbamazepine, valproic acid, bupropion	Conditional, against	Harms outweighed benefits (for bupropion, they were balanced)1
Cabergoline	Strong, against	Harms outweighed benefits1
Acupuncture, yoga, CBT, vitamin D, tramadol	No recommendation	Too little evidence to judge1

NINDS says the FDA approved this tonic motor activation system, which NINDS helped fund⁴.

Worn on the lower legs, it electrically stimulates a nerve on each side¹². In a four-week trial of 133 adults whose RLS hadn’t responded to medicines, 45% counted as responders on the device, compared with 16% on a sham version¹².

The maker, Noctrix Health, paid for that trial, and a company employee was an author¹². Winkelman, who later chaired the guideline panel, served as a consultant and independent medical monitor for the company¹². We couldn’t check the guideline’s own disclosure list.

Iron works like a medicine here, so test before you take it

Don’t start iron pills on your own. The AASM ties iron treatment to blood test results¹, and the NIH Office of Dietary Supplements (ODS) explains why guessing is risky:

• There’s a ceiling. The upper limit for adults is 45 mg of iron a day, though clinicians sometimes prescribe more for a diagnosed deficiency⁹.
• Some bodies already hold too much. About 4.4 in 1,000 White people have hereditary hemochromatosis, a genetic condition that loads the body with iron, and a liver specialists’ group advises them to avoid iron supplements⁹. High test results can point to it¹¹.
• It interacts with medicines. Iron can cut absorption of levodopa, used for RLS and Parkinson’s disease, and of levothyroxine, a thyroid drug⁹.
• It’s dangerous to children. An FDA-required label warns that iron overdose is a leading cause of fatal poisoning in children under 6⁹.

Ferrous sulfate is 20% iron by weight⁹. So a 325 mg tablet would hold about 65 mg of iron, by our math, already above the 45 mg limit. Let a clinician who has seen your numbers set the dose.

How to get tested

The AASM advises a morning blood draw, with no iron pills or iron-containing foods for at least 24 hours before¹. Your clinician may also ask you to fast¹¹. Ask for both ferritin and transferrin saturation¹.

Winkelman has suggested 48 hours without iron pills or red meat³, so ask which rule your clinician prefers.

For adults, the guideline considers oral or IV iron when ferritin is 75 ng/mL or lower, or saturation is below 20%¹. When ferritin falls between 75 and 100, it considers IV iron only¹. Those cutoffs come from expert agreement, not head-to-head testing¹.

IV iron has its own risks

On September 1, 2026, the FDA added a boxed warning, its most prominent kind, to ferric carboxymaltose (Injectafer)¹⁰. The warning covers low blood phosphate that causes symptoms. Severe, lasting cases can soften bones and lead to fractures¹⁰.

The FDA found phosphate was checked in fewer than 20% of treatment episodes¹⁰. RLS isn’t among its approved uses, so using it for RLS is off-label¹⁰. Serious allergic reactions, some fatal, have also occurred, so clinics watch patients for at least 30 minutes after each dose¹⁰.

If you’re offered IV iron, ask whether your phosphate will be checked, especially before a repeat dose within three months¹⁰.

Your medicine cabinet and evening habits can feed the urge

The guideline’s first step is removing what makes RLS worse: alcohol, caffeine, untreated sleep apnea, and medicines with antihistamine, serotonin or dopamine-blocking effects¹.

NINDS and MedlinePlus name specific culprits⁴⁶:

• some antihistamines and some anti-nausea drugs;
• antidepressants that raise serotonin;
• antipsychotics and lithium;
• calcium channel blockers, a type of blood pressure medicine;
• nicotine, alcohol and caffeine;
• stopping a sedative;
• too little sleep.

If you use an allergy pill or nighttime sleep aid, ask a pharmacist whether it holds a sedating antihistamine. Never stop a prescription on your own; ask about alternatives.

This is where natural-health habits shine. Cutting back on caffeine, alcohol and tobacco, keeping regular sleep hours, and asking whether you still need each pill are exactly what the guideline and NINDS put first¹⁴.

Home remedies: exercise has the best evidence

In a 2006 trial funded by East Tennessee State University, people were assigned by chance to exercise or not¹³. For 12 weeks, one group walked on a treadmill for 30 minutes and did six lower-body strength exercises, three times a week¹³. The other group got only lifestyle advice¹³.

By week 6, symptom severity had dropped 39% in the exercise group and less than 8% in the comparison group¹³.

It was small, though. Only 23 people finished, and nobody could be blinded to their group¹³. The authors reported no conflicts¹³.

NINDS also suggests a leg massage or warm bath, a heating pad or ice pack, and foot wraps or vibration pads made for RLS⁴. These are low-risk, but we didn’t find strong trials to cite.

Magnesium: popular, barely studied

Magnesium is often suggested for RLS, mostly from personal reports and its use for leg cramps¹⁴. A 2019 review in Sleep Medicine Reviews found just one randomized trial, and it showed no clear benefit, possibly because it was too small¹⁴. The authors couldn’t say whether magnesium works¹⁴. Our article on magnesium covers doses and safety.

Night leg cramps are a different problem with different fixes. See our article on gentle stretching.

Approach	What the research shows	Evidence level
IV iron when tests qualify	Modest benefit, moderate certainty18	Strong evidence
Oral iron when tests qualify	Conditional support; fewer trials18	Promising but early
Dopamine drugs	Work at first, but augmentation builds35	Strong evidence short term; Evidence says no, or unsafe for routine long-term use
Leg nerve stimulation device	One company-funded, four-week trial12	Promising but early
Regular exercise	One small trial of 23 finishers13	Promising but early
Cutting caffeine, alcohol, nicotine	Advised by the AASM and NINDS14	Not enough evidence from trials we found, but low-risk
Massage, baths, heat or cold	Suggested by NINDS; no strong trials found4	Not enough evidence
Magnesium	One small, negative trial14	Not enough evidence
Valerian	The guideline suggests against it; harms outweighed benefits1	Evidence says no, or unsafe

Pregnancy, kidney disease and children need their own plans

Pregnancy. About 1 in 5 pregnant women in Western countries has RLS, often with real sleep loss, according to the International Restless Legs Syndrome Study Group¹⁵. It’s most likely in the last trimester and usually clears within four weeks after delivery⁴⁵.

The study group’s guidance starts with reassurance, exercise and avoiding triggers, and it explains why iron can help¹⁵. The AASM says to weigh each treatment’s safety in pregnancy¹. The recommended iron intake in pregnancy is 27 mg a day⁹. Before adding iron to a prenatal vitamin, ask your obstetric clinician for a ferritin test.

Kidney disease. RLS is linked to kidney failure and dialysis⁴. For people with end-stage kidney disease, the AASM suggests gabapentin, IV iron sucrose when ferritin is under 200 and saturation is under 20%, and vitamin C¹. All three are conditional¹, and your kidney team should set doses.

Children. The AASM suggests oral iron for children with RLS when ferritin is below 50¹. Keep every iron product locked away from small children⁹.

Your restless legs action plan

This plan is our own, built from the AASM guideline and NIH guidance.

1. Keep a two-week diary. Each evening, note when symptoms started, what you were doing, a 0-to-10 rating, caffeine, alcohol, medicines and hours slept.
2. Ask for two iron tests. Request ferritin and transferrin saturation, drawn in the morning, with no iron pills or iron-rich foods for 24 hours before¹. Write down the numbers, not just “normal.”
3. Bring every bottle. Include prescriptions, allergy pills, sleep aids and supplements. Ask which could be making RLS worse¹⁴.
4. Build a nightly routine. Keep regular sleep hours, exercise moderately, and try a leg massage, warm bath, or heat or cold pack before bed⁴¹³.
5. Weigh the options. Discuss iron if your numbers qualify, plus the guideline’s medicines and device and their trade-offs¹.

When to see a clinician:

• You have symptoms of RLS⁶.
• Your sleep is disrupted⁶.
• Your symptoms are getting worse⁶.
• You take a dopamine drug, and symptoms now start earlier in the day or have spread to your arms or trunk⁵.
• After IV iron, you have new or worsening muscle weakness or pain, fatigue, bone or joint pain, or confusion¹⁰.

A later article covers when sleep problems need a full workup.

Questions readers ask

The bottom line

Restless legs syndrome is real, common and often missed. The best current advice starts with steps natural-health readers will recognize: fix sleep habits, cut caffeine and alcohol, question every medicine and move your body.

Then comes iron, used as a medicine, not a guess, after a blood test. If you need a prescription, know that the old dopamine drugs can backfire over time, and that newer first choices carry trade-offs of their own.

Related reading

• Some healthy habits clash with your medicines, so check these goals first
• A stack of safe supplements can add up to an unsafe dose
• Memory rewrites your symptoms, and a diary keeps the record straight
• A big caffeine dose 12 hours before bed can still cut deep sleep
• Magnesium went viral as a sleep aid, and careful trials find a small effect

Sources

1. Winkelman JW, Berkowski JA, DelRosso LM, et al. “Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder: An American Academy of Sleep Medicine Clinical Practice Guideline.” Journal of Clinical Sleep Medicine, 2025;21(1):137–152 (published online September 2024); summarized in AASM, “RLS and PLMD Guideline at a Glance,” 2025. pubmed.ncbi.nlm.nih.gov
2. Nonacs R. “Updated Guidelines for the Treatment of Restless Leg Syndrome: New Research Prompts a Significant Shift in Recommendations.” MGH Center for Women’s Mental Health / MGH Psychiatry News, December 3, 2024. mghpsychnews.org
3. Derman C. “AASM Updates Clinical Guidelines for Restless Legs Syndrome” (interview with John Winkelman, MD, PhD). HCPLive, November 22, 2024. hcplive.com
4. National Institute of Neurological Disorders and Stroke. “Restless Legs Syndrome.” NIH, last reviewed March 13, 2026. ninds.nih.gov
5. National Institute of Neurological Disorders and Stroke. “Restless Legs Syndrome” (fact sheet, NIH Publication No. 17-4847). NIH, 2017. ninds.nih.gov
6. MedlinePlus Medical Encyclopedia. “Restless Legs Syndrome.” National Library of Medicine, reviewed July 17, 2025. medlineplus.gov
7. Allen RP, Walters AS, Montplaisir J, et al. “Restless Legs Syndrome Prevalence and Impact: REST General Population Study.” Archives of Internal Medicine, 2005;165(11):1286–1292. rti.org
8. Trotti LM, Becker LA. “Iron for the Treatment of Restless Legs Syndrome.” Cochrane Database of Systematic Reviews, 2019, CD007834. cochrane.org
9. NIH Office of Dietary Supplements. “Iron: Fact Sheet for Health Professionals.” Updated September 4, 2025. ods.od.nih.gov
10. U.S. Food and Drug Administration. “FDA Adds Boxed Warning to Labeling for Ferric Carboxymaltose Injection (Injectafer) to Describe Risk of Low Phosphate Levels.” Drug Safety Communication, September 1, 2026; and Injectafer prescribing information, revised January 2025. fda.gov and accessdata.fda.gov
11. MedlinePlus. “Iron Tests.” National Library of Medicine, updated April 10, 2024. medlineplus.gov
12. Bogan RK, Roy A, Kram J, et al. “Efficacy and Safety of Tonic Motor Activation (TOMAC) for Medication-Refractory Restless Legs Syndrome: A Randomized Clinical Trial.” Sleep, 2023;46(10). pubmed.ncbi.nlm.nih.gov
13. Aukerman MM, Aukerman D, Bayard M, et al. “Exercise and Restless Legs Syndrome: A Randomized Controlled Trial.” Journal of the American Board of Family Medicine, 2006;19(5):487–493. jabfm.org
14. Marshall NS, Serinel Y, Killick R, et al. “Magnesium Supplementation for the Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder: A Systematic Review.” Sleep Medicine Reviews, 2019;48:101218. researchers.mq.edu.au
15. Picchietti DL, Hensley JG, Bainbridge JL, et al. “Consensus Clinical Practice Guidelines for the Diagnosis and Treatment of Restless Legs Syndrome/Willis-Ekbom Disease During Pregnancy and Lactation.” Sleep Medicine Reviews, 2015;22:64–77. em-consulte.com